T-MAXIMUM is currently focused on late-stage malignant tumors, and its lead program for recurrent glioma has received clearance to enter Phase II clinical trials. Over the next three years, the ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side ...

Biotechnology company Leucid Bio announced a strategic collaboration with Syenex, an open-source gene therapy platform firm.

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the 'Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.

The cell therapy manufacturing sector reached a pivotal inflection point in late 2025, with contract development and ...

Now, with the European Union Health Technology Assessment (HTA) regulation coming into force as part of the required Joint Clinical Assessment (JCA) for oncology and advanced therapy medicinal ...

Cell phones and screens can help kids learn in school. In an increasingly technological world, prudent use of technology will ...

Bristol-Myers Squibb Company (NYSE: BMY) is one of the best stocks to buy for the next 5 years. On December 15, Goldman Sachs ...

Authorities announced they tracked down the man responsible for the deadly Brown University shooting that rocked the Ivy ...

The global shift toward cheaper Lithium Iron Phosphate (LFP) batteries is a strategic surrender of the Western battery lead, ...

Flock Safety technology helped Providence Police track down 48-year-old Claudio Neves Valente, who police say was responsible for both the Brown University shooting and the killing of an MIT professor ...

Claudio Neves Valente, the suspect in the Brown University mass shooting, was found dead tonight after taking his own life, Providence Chief of Police Oscar L. Perez, Jr. said. Follow for live news ...